Article Details
Retrieved on: 2021-03-15 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
We are excited to work with Johns Hopkins investigators on this exciting frontier in immunotherapy,” said Dr. Mark Schoenberg, Chief Medical Officer of ...
Article found on: www.oaoa.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here